Max Yan

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 649 citations · Full text

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers

Max Yan, Nicholas Jene, David J. Byrne et al. · Breast Cancer Research · 2011 · 170 citations · Full text

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Anna Marie Mulligan, Fergus J. Couch, Daniel Barrowdale et al. · Breast Cancer Research · 2011 · 118 citations · Full text

Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers

Huiling Xu, Max Yan, Jennifer Patra et al. · Breast Cancer Research · 2011 · 104 citations · Full text

Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers

Max Yan, Huiling Xu, Nicola Waddell et al. · Breast Cancer Research · 2012 · 53 citations · Full text